Cargando…
Vesiculopolins, a New Class of Anti-Vesiculoviral Compounds, Inhibit Transcription Initiation of Vesiculoviruses
Vesicular stomatitis virus (VSV) represents a promising platform for developing oncolytic viruses, as well as vaccines against significant human pathogens. To safely control VSV infection in humans, small-molecule drugs that selectively inhibit VSV infection may be needed. Here, using a cell-based h...
Autores principales: | Ogino, Minako, Fedorov, Yuriy, Adams, Drew J., Okada, Kazuma, Ito, Naoto, Sugiyama, Makoto, Ogino, Tomoaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783830/ https://www.ncbi.nlm.nih.gov/pubmed/31540123 http://dx.doi.org/10.3390/v11090856 |
Ejemplares similares
-
The Rabies Virus L Protein Catalyzes mRNA Capping with GDP Polyribonucleotidyltransferase Activity
por: Ogino, Minako, et al.
Publicado: (2016) -
A dual-functional priming-capping loop of rhabdoviral RNA polymerases directs terminal de novo initiation and capping intermediate formation
por: Ogino, Minako, et al.
Publicado: (2019) -
Reviewing Chandipura: A Vesiculovirus in Human Epidemics
por: Basak, Soumen, et al.
Publicado: (2007) -
GDP polyribonucleotidyltransferase domain of vesicular stomatitis virus polymerase regulates leader-promoter escape and polyadenylation-coupled termination during stop-start transcription
por: Ogino, Minako, et al.
Publicado: (2022) -
Signature motifs of GDP polyribonucleotidyltransferase, a non-segmented negative strand RNA viral mRNA capping enzyme, domain in the L protein are required for covalent enzyme–pRNA intermediate formation
por: Neubauer, Julie, et al.
Publicado: (2016)